Early results of an industry-sponsored, human-safety study on hemp-derived CBD consumption show no evidence of liver toxicity or disease in its 839 participants.
Industry to FDA: No evidence of liver disease or elevated liver function in CBD study participants is a post from: Hemp Industry Daily: Financial, Legal & business news for hemp & CBD entrepreneurs
From Industry to FDA: No evidence of liver disease or elevated liver function in CBD study participants on CBD Products & CBD Business News – Hemp Industry Daily.
This was autoposted by IFTTT. To find out more, read my post about news articles.
No comments:
Post a Comment